Regulation of the human plasminogen activator inhibitor type 2 gene: Cooperation of an upstream silencer and transactivator

Journal of Biological Chemistry

Volumn 287, Issue 13, 2012, Pages 10579-10589

  Stringer, Brett ^b   Udofa, Ekemini A ^a   Antalis, Toni M ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CELL TYPES; CELLULAR STRESS; CYTOKINES; DE-REPRESSION; GENE PROMOTER; GROWTH FACTOR; HELA CELL; KERATINOCYTES; MACROPHAGE-LIKE CELLS; MOLECULAR BASIS; OVER-EXPRESSION; PHORBOL ESTERS; PLASMINOGEN ACTIVATOR INHIBITOR; POTENT ACTIVATORS; PROTEIN KINASE C; REGULATORY DOMAIN; TISSUE-SPECIFIC EXPRESSION; TRANSACTIVATORS; TRANSCRIPTIONAL CONTROL; U937 CELL; UP-REGULATION;

CELL CULTURE; GENES; MACROPHAGES; TISSUE;

TRANSCRIPTION;

MESSENGER RNA; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR FOSB;

ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMALE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PLASMINOGEN ACTIVATOR INHIBITOR TYPE 2 GENE; PRIORITY JOURNAL; PROMOTER REGION; TISSUE SPECIFICITY; TRANSACTIVATION; TRANSCRIPTION REGULATION; TRANSCRIPTION TERMINATION; TRANSIENT TRANSFECTION;

CARCINOGENS; ENZYME ACTIVATORS; HELA CELLS; HUMANS; KERATINOCYTES; MACROPHAGES; MODELS, BIOLOGICAL; MONOCYTES; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RESPONSE ELEMENTS; SILENCER ELEMENTS, TRANSCRIPTIONAL; TETRADECANOYLPHORBOL ACETATE; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; U937 CELLS;

EID: 84858976956     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.318758     Document Type: Article

References (51)

1. Potempa, J., Korzus, E., and Travis, J. (1994) The serpin superfamily of proteinase inhibitors. Structure, function, and regulation. J. Biol. Chem. 269, 15957-15960 (Pubitemid 24209273)
2. Silverman, G. A., Bird, P. I., Carrell, R. W., Church, F. C., Coughlin, P. B., Gettins, P. G., Irving, J. A., Lomas, D. A., Luke, C. J., Moyer, R. W., Pemberton, P. A., Remold-O'Donnell, E., Salvesen, G. S., Travis, J., and Whisstock, J. C. (2001) The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276, 33293-33296
3. Law, R. H., Zhang, Q., McGowan, S., Buckle, A. M., Silverman, G. A., Wong, W., Rosado, C. J., Langendorf, C. G., Pike, R. N., Bird, P. I., and Whisstock, J. C. (2006) An overview of the serpin superfamily. Genome Biol. 7, 216
4. Kawano, T., Morimoto, K., and Uemura, Y. (1968) Urokinase inhibitor in human placenta. Nature 217, 253-254
5. Park, J. M., Greten, F. R., Wong, A., Westrick, R. J., Arthur, J. S., Otsu, K., Hoffmann, A., Montminy, M., and Karin, M. (2005) Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis. CREB and NF-κB as key regulators. Immunity 23, 319-329 (Pubitemid 41319727)
6. Kruithof, E. K., Baker, M. S., and Bunn, C. L. (1995) Biological and clinical aspects of plasminogen activator inhibitor type 2. Blood 86, 4007-4024
7. Risse, B. C., Brown, H., Lavker, R. M., Pearson, J. M., Baker, M. S., Ginsburg, D., and Jensen, P. J. (1998) Differentiating cells of murine stratified squamous epithelia constitutively express plasminogen activator inhibitor type 2 (PAI-2). Histochem. Cell Biol. 110, 559-569 (Pubitemid 28535611)
8. Andela, V. B., Schwarz, E. M., Puzas, J. E., O'Keefe, R. J., and Rosier, R. N. (2000) Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor kB. Cancer Res. 60, 6557-6562
9. Shafren, D. R., Gardner, J., Mann, V. H., Antalis, T. M., and Suhrbier, A. (1999) Picornavirus receptor down-regulation by plasminogen activator inhibitor type 2. J. Virol. 73, 7193-7198 (Pubitemid 29383200)
10. Dickinson, J. L., Bates, E. J., Ferrante, A., and Antalis, T. M. (1995) Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor α-induced apoptosis. Evidence for an alternate biological function. J. Biol. Chem. 270, 27894-27904
11. Kumar, S., and Baglioni, C. (1991) Protection from tumor necrosis factor-mediated cytolysis by overexpression of plasminogen activator inhibitor type-2. J. Biol. Chem. 266, 20960-20964 (Pubitemid 21908558)
12. Gan, H., Newman, G. W., and Remold, H. G. (1995) Plasminogen activator inhibitor type 2 prevents programmed cell death of human macrophages infected with Mycobacterium avium, serovar 4. J. Immunol. 155, 1304-1315
13. Zhou, H. M., Bolon, I., Nichols, A., Wohlwend, A., and Vassalli, J. D. (2001) Overexpression of plasminogen activator inhibitor type 2 in basal keratinocytes enhances papilloma formation in transgenic mice. Cancer Res. 61, 970-976 (Pubitemid 32174413)
14. Schroder, W. A., Gardner, J., Le, T. T., Duke, M., Burke, M. L., Jones, M. K., McManus, D. P., and Suhrbier, A. (2010) SerpinB2 deficiency modulates Th1Th2 responses after schistosome infection. Parasite Immunol. 32, 764-768
15. Ohkuchi, A., Minakami, H., Aoya, T., Haga, T., Kimura, H., Suzuki, M., and Sato, I. (2001) Expansion of the fraction of Th1 cells in women with preeclampsia. Inverse correlation between the percentage of Th1 cells and the plasma level of PAI-2. Am. J. Reprod. Immunol. 46, 252-259 (Pubitemid 32926905)
16. Roes, E. M., Sweep, C. G., Thomas, C. M., Zusterzeel, P. L., Geurts-Moespot, A., Peters, W. H., and Steegers, E. A. (2002) Levels of plasminogen activators and their inhibitors in maternal and umbilical cord plasma in severe preeclampsia. Am. J. Obstet. Gynecol. 187, 1019-1025 (Pubitemid 35178405)
17. Woodruff, P. G., Boushey, H. A., Dolganov, G. M., Barker, C. S., Yang, Y. H., Donnelly, S., Ellwanger, A., Sidhu, S. S., Dao-Pick, T. P., Pantoja, C., Erle, D. J., Yamamoto, K. R., and Fahy, J. V. (2007) Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc. Natl. Acad. Sci. U.S.A. 104, 15858-15863 (Pubitemid 350035389)
18. Beikler, T., Peters, U., Prior, K., Eisenacher, M., and Flemmig, T. F. (2008) Gene expression in periodontal tissues following treatment. BMC Med. Genomics 1, 30
19. Croucher, D. R., Saunders, D. N., Lobov, S., and Ranson, M. (2008) Revisiting the biological roles of PAI2 (SERPINB2) in cancer. Nat. Rev. Cancer 8, 535-545 (Pubitemid 351881848)
20. Medcalf, R. L., and Stasinopoulos, S. J. (2005) The undecided serpin. The ins and outs of plasminogen activator inhibitor type 2. FEBS J. 272, 4858-4867 (Pubitemid 41415110)
21. Medcalf, R. L. (2011) Plasminogen activator inhibitor type 2. Still an enigmatic serpin but a model for gene regulation. Methods Enzymol. 499, 105-134
22. Musashi, M., Ota, S., and Shiroshita, N. (2000) The role of protein kinase C isoforms in cell proliferation and apoptosis. Int. J. Hematol. 72, 12-19
23. Ron, D., and Kazanietz, M. G. (1999) New insights into the regulation of protein kinase C and novel phorbol ester receptors. FASEB J. 13, 1658-1676 (Pubitemid 29473329)
24. Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., and Karin, M. (1987) Phorbol ester-inducible genes contain a common cis-element recognized by a TPA-modulated transacting factor. Cell 49, 729-739 (Pubitemid 18094763)
25. Chiu, R., Imagawa, M., Imbra, R. J., Bockoven, J. R., and Karin, M. (1987) Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters. Nature 329, 648-651 (Pubitemid 17140119)
26. Angel, P., and Karin, M. (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157 (Pubitemid 121007534)
27. Shaulian, E. (2010) AP-1-The Jun proteins. Oncogenes or tumor suppressors in disguise? Cell Signal. 22, 894-899
28. Milde-Langosch, K. (2005) The Fos family of transcription factors and their role in tumourigenesis. Eur. J. Cancer 41, 2449-2461
29. Antalis, T. M., Costelloe, E., Muddiman, J., Ogbourne, S., and Donnan, K. (1996) Regulation of the plasminogen activator inhibitor type-2 gene in monocytes. Localization of an upstream transcriptional silencer. Blood 88, 3686-3697 (Pubitemid 26383090)
30. Ogbourne, S. M., and Antalis, T. M. (2001) Characterisation of PAUSE-1, a powerful silencer in the human plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res. 29, 3919-3927 (Pubitemid 32962681)
31. Antalis, T. M., Godbolt, D., Donnan, K. D., and Stringer, B. W. (1993) Southwestern blot mapping of potential regulatory proteins binding to the DNA encoding plasminogen activator inhibitor type 2. Gene 134, 201-208
32. Kruithof, E. K., and Cousin, E. (1988) Plasminogen activator inhibitor 2. Isolation and characterization of the promoter region of the gene. Biochem. Biophys. Res. Commun. 156, 383-388
33. Ho, S. N., Hunt, H. D., Horton, R. M., Pullen, J. K., and Pease, L. R. (1989) Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77, 51-59 (Pubitemid 19125653)
34. Antalis, T. M., and Godbolt, D. (1991) Isolation of intact nuclei from hematopoietic cell types. Nucleic Acids Res. 19, 4301
35. Liberati, N. T., Datto, M. B., Frederick, J. P., Shen, X., Wong, C., Rougier-Chapman, E. M., and Wang, X. F. (1999) Smads bind directly to the Jun family of AP-1 transcription factors. Proc. Natl. Acad. Sci. U.S.A. 96, 4844-4849 (Pubitemid 29214499)
36. Imagawa, M., Chiu, R., and Karin, M. (1987) Transcription factor AP-2 mediates induction by two different signal-transduction pathways. Protein kinase C and cAMP. Cell 51, 251-260
37. Edbrooke, M. R., Burt, D. W., Cheshire, J. K., and Woo, P. (1989) Identification of cis-acting sequences responsible for phorbol ester induction of human serum amyloid A gene expression via a nuclear factor kB-like transcription factor. Mol. Cell Biol. 9, 1908-1916 (Pubitemid 19117789)
38. Pulverer, B. J., Hughes, K., Franklin, C. C., Kraft, A. S., Leevers, S. J., and Woodgett, J. R. (1993) Co-purification of mitogen-activated protein kinases with phorbol ester-induced c-Jun kinase activity in U937 leukaemic cells. Oncogene 8, 407-415 (Pubitemid 23073757)
39. Yoshioka, K., Deng, T., Cavigelli, M., and Karin, M. (1995) Antitumor promotion by phenolic antioxidants. Inhibition of AP-1 activity through induction of Fra expression. Proc. Natl. Acad. Sci. U.S.A. 92, 4972-4976
40. Doyle, G. A., Pierce, R. A., and Parks, W. C. (1997) Transcriptional induction of collagenase-1 in differentiated monocyte-like (U937) cells is regulated by AP-1 and an upstream C/EBP-β site. J. Biol. Chem. 272, 11840-11849 (Pubitemid 27202753)
41. Lamph, W. W., Wamsley, P., Sassone-Corsi, P., and Verma, I. M. (1988) Induction of proto-oncogene JUN/AP-1 by serum and TPA. Nature 334, 629-631
42. Cousin, E., Medcalf, R. L., Bergonzelli, G. E., and Kruithof, E. K. (1991) Regulatory elements involved in constitutive and phorbol ester-inducible expression of the plasminogen activator inhibitor type 2 gene promoter. Nucleic Acids Res. 19, 3881-3886 (Pubitemid 21912756)
43. Rajaram, N., and Kerppola, T. K. (1997) DNA bending by Fos-Jun and the orientation of heterodimer binding depend on the sequence of the AP-1 site. EMBO J. 16, 2917-2925 (Pubitemid 27226227)
44. Ramirez-Carrozzi, V. R., and Kerppola, T. K. (2001) Long-range electrostatic interactions influence the orientation of Fos-Jun binding at AP-1 sites. J. Mol. Biol. 305, 411-427 (Pubitemid 33032850)
45. Dickinson, J. A., Amato, S. F., McManus, B. J., and Chiles, T. C. (1995) Membrane immunoglobulin receptor cross-linking induces fosB mRNA expression in mature B lymphocytes. Assembly of distinct FosB-containing nucleoprotein complexes during B cell stimulation. Cell Immunol. 165, 92-100
46. Welter, J. F., and Eckert, R. L. (1995) Differential expression of the fos and jun family members c-fos, fosB, Fra-1, Fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation. Oncogene 11, 2681-2687 (Pubitemid 26023837)
47. Lyons-Giordano, B., Loskutoff, D., Chen, C. S., Lazarus, G., Keeton, M., and Jensen, P. J. (1994) Expression of plasminogen activator inhibitor type 2 in normal and psoriatic epidermis. Histochemistry 101, 105-112 (Pubitemid 24110023)
48. Smith, R., Xue, A., Gill, A., Scarlett, C., Saxby, A., Clarkson, A., and Hugh, T. (2007) High expression of plasminogen activator inhibitor-2 (PAI-2) is a predictor of improved survival in patients with pancreatic adenocarcinoma. World J. Surg. 31, 493-502 (Pubitemid 46356075)
49. Chambers, S. K., Ivins, C. M., and Carcangiu, M. L. (1997) Expression of plasminogen activator inhibitor-2 in epithelial ovarian cancer.Afavorable prognostic factor related to the actions of CSF-1. Int. J Cancer 74, 571-575 (Pubitemid 28037496)
50. Nordengren, J., Fredstorp Lidebring, M., Bendahl, P. O., Brünner, N., Fernö, M., Högberg, T., Stephens, R. W., Willén, R., and Casslén, B. (2002) High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer. Int. J Cancer 97, 379-385 (Pubitemid 34049032)
51. Ganesh, S., Sier, C. F., Heerding, M. M., van Krieken, J. H., Griffioen, G., Welvaart, K., van de Velde, C. J., Verheijen, J. H., Lamers, C. B., and Verspaget, H. W. (1997) Contribution of plasminogen activators and their inhibitors to the survival prognosis of patients with Dukes' stage B and C colorectal cancer. Br. J Cancer 75, 1793-1801 (Pubitemid 27230706)